This page describes pharmacological agents that may have legal restrictions, side effects, and drug interactions in your jurisdiction. Information is for educational research only — consult a clinician before considering any compound.
Surface here is educational only; do not use without medical supervision. Our editorial verdict is SKIP-FOR-NOW — current cost / risk / redundancy puts it below the line.
Cortexin
Russian Rx neurology drug (registered since 1999) — a lyophilized hydrolysate of bovine or porcine cerebral cortex peptides, fractionated…
Aliases (5)
Overview
What is Cortexin?
Cortexin is a Russian-developed polypeptide preparation extracted from bovine or porcine cerebral cortex, marketed in Russia and CIS countries for stroke recovery, encephalopathy, and pediatric neurology. It is administered intramuscularly.
Key Benefits
Reported neuroprotection, cognitive recovery after stroke or brain injury, and improvement in pediatric perinatal CNS conditions. Anecdotal nootropic use for memory and focus, particularly during cognitive recovery phases.
Mechanism of Action
Mixture of low-molecular-weight neuropeptides and amino acids that putatively modulate neurotrophic factor expression (BDNF, NGF), GABA/glutamate balance, and antioxidant defense. Mechanism remains poorly characterized in Western literature.
Molecular Information
Type
Tetrapeptide
Amino Acid Sequence:
Glu-Asp-Arg
▸ Reconstitution Lyophilized peptide
Reconstitute lyophilized peptide with bacteriostatic water (BAC) using sterile technique. Calculator below converts vial mg + diluent mL into syringe units.
- 1 Wipe BAC water vial + peptide vial stoppers with isopropyl alcohol.
- 2 Draw the planned diluent volume into a 1 mL syringe.
- 3 Inject diluent slowly down the inside wall of the peptide vial — do NOT spray onto powder.
- 4 Swirl gently (do not shake) until fully dissolved. Solution should be clear.
- 5 Label vial with date reconstituted; refrigerate 2-8 °C.
- 6 Use within 30 days for most peptides (BPC-157 / TB-500 ~ 60 days at 4 °C).
Research Indications
GABA modulation
Cortexin is reported to enhance GABA-ergic tone, contributing to anxiolytic and anti-epileptic effects observed in Russian clinical pract…
Antioxidant activity
claimed reduction in lipid peroxidation and improvement in superoxide dismutase / catalase activity in animal models.
Anti-apoptotic
claimed reduction in caspase-3 / pro-apoptotic signaling in stressed neurons (same broad claim made for Pinealon and Cerebrolysin).
Neurotrophic factor mimicry
claimed to mimic or upregulate BDNF / NGF, supporting neuronal survival and synaptic plasticity. Weakly characterized.
BBB penetration
claimed for the small-peptide fraction of the complex; not formally PK-characterized.
Peptide Interactions
Mechanistically redundant. Cortexin and Cerebrolysin are both animal-cortex peptide hydrolysates with the same neurotrophic-cocktail claim. Running both is t…
Mechanistically complementary (Semax acts on melanocortin / BDNF / neurotrophic axes; Cortexin's broad peptide-cocktail mechanism is too poorly characterized…
(NAC, curcumin, astaxanthin, vitamin C) — likely additive if anything, no interaction concern.
simultaneously — redundancy without benefit. Run them in separate cycles if running both.
(Pinealon, Cerluten, Vesugen) — running multiple Khavinson-network products at once makes attribution impossible and stacks the same single-source-evidence p…
Quality Indicators
White, fluffy cake (peptides)
Lyophilized peptide should appear as a white, fluffy "cake" filling most of the vial bottom. Indicates proper freeze-drying.
Clear solution after reconstitution
After mixing with bacteriostatic water, the solution should be crystal clear with no particles or cloudiness.
Slight clumping acceptable
Small clumps that fully dissolve with gentle swirling are normal — shipping can cause minor compaction.
Collapsed or melted powder
Powder that looks collapsed, melted, or stuck to vial sides may have been heat-damaged in transit.
Cloudy or particulate solution
Persistent cloudiness or visible particles after gentle mixing indicate degraded or contaminated material.
What to Expect
- Day 1-7Injection / administration protocol established. Tolerability check.
- Week 2-4Early onset of effect — subtle in most users, noticeable in responders.
- Week 4-8Peak benefit window for most peptide cycles.
- Week 8+Cycle decision point: continue, taper, or break.
Side Effects & Safety 3
Side Effects
- 1Injection site reaction — local pain, redness, occasional itching. Mild and transient. Most common when reconstituted with saline rather than procaine.
- 2Mild headache during initial doses. Self-resolves.
- 3Mild GI discomfort — uncommon.
When to Stop
- Allergic reaction to peptide complex or excipients. Discontinue if hives / swelling / rash develop. Animal-derived peptide hydrolysate carries theoretically higher allergic-reaction risk than synthetic peptides, though clinical reports are rare.
- Theoretical prion / TSE concern (animal-derived): Cortexin is sourced from young calf or pig cerebral cortex. Manufacturers claim sourcing from BSE-free herds and processing methods that inactivate prions. The theoretical risk of bovine spongiform encephalopathy or other transmissible spongiform encephalopathy contamination in animal-CNS-derived products is real but considered low with proper sourcing — the same theoretical concern applies to Cerebrolysin (porcine brain) and is generally regarded as adequately mitigated by manufacturer practices. Not a practical contraindication, but worth flagging for any animal-CNS-derived product.
- No documented organ toxicity in available preclinical literature; no documented dependence; no withdrawal syndrome.
- First 1-2 doses: monitor for allergic reaction to animal-derived peptide complex.
- Each course: standard injection-site monitoring.
- Active malignancy contraindication (theoretical, family-wide): broad pro-survival / anti-apoptotic peptide signaling could theoretically support malignant cell survival. Not personally relevant to the user (no oncologic history).
- Stacking with other strongly-pro-survival compounds (BPC-157, TB-500, Cerebrolysin, IGF-1): cumulative pro-survival pressure on cells from stacked anabolic / regenerative peptides is unstudied. Same theoretical concern as for Pinealon.
- No CYP enzyme interactions documented — peptide metabolism via peptidases. Should be drug-interaction-clean.
References
Voronina TA, Molodavkin GM, Borlikova GG, Kapitsa IG, Vakhitova YV, Seredenin SB. "Neuroprotective action of Cortexin, Cerebrolysin and Actovegin in acute or chronic brain ischemia in rats." PLoS One 2021;16(7):e0254493. **PMID: 34255796**
Head-to-head preclinical comparison: Cortexin (1 or 3 mg/kg) and Cerebrolysin (538 or 1614 mg/kg) showed comparable efficacy in acute and chronic brain ischemia models. The single most useful Corte…
View StudyGeropharm Cortexin product information
manufacturer's product literature (Russian primary).
View StudyCosmicNootropic Cortexin product page
Russian Rx product, IM injectable, 10×10mg vials.
View StudyCortexin Wikipedia (Russian)
sequence-level mechanism summary, mostly from Russian sources.
View StudyHow was your experience with this compound?
Anonymous · one vote per session · results below at 5+ votes.
See something off?
Most of this wiki is AI-generated. Suggest a correction, dosing update, or new evidence — we review every submission.